Skip to main content
Premium Trial:

Request an Annual Quote

Target Discovery and PrecisionMed to Study Peptides in Childhood Autism

NEW YORK, April 6 (GenomeWeb News) - Target Discovery and PrecisionMed will collaborate to study the role of certain peptides in childhood autism, the companies said today.

 

Under the agreement, Target Discovery, based in Palo Alto, Calif., will use its technology to determine the source of opioid-like peptides in samples from autistic children provided by PrecisionMed, located in San Diego.

 

Target Discovery has been working on a protein separation platform based on capillary electrophoresis and mass spectrometry.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.